Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.

Weitzner E, McKenna D, Nowakowski J, Scavarda C, Dornbush R, Bittker S, Cooper D, Nadelman RB, Visintainer P, Schwartz I, Wormser GP.

Clin Infect Dis. 2015 Dec 15;61(12):1800-6. doi: 10.1093/cid/civ735. Epub 2015 Sep 18.

2.

Long-term follow-up of patients with culture-confirmed Lyme disease.

Nowakowski J, Nadelman RB, Sell R, McKenna D, Cavaliere LF, Holmgren D, Gaidici A, Wormser GP.

Am J Med. 2003 Aug 1;115(2):91-6.

PMID:
12893393
3.

Comparison of males versus females with culture-confirmed early Lyme disease at presentation and at 11-20 years after diagnosis.

Weitzner E, Visintainer P, Wormser GP.

Diagn Microbiol Infect Dis. 2016 Aug;85(4):493-5. doi: 10.1016/j.diagmicrobio.2016.04.012. Epub 2016 Apr 23.

PMID:
27230991
4.

Comparison of post-Lyme Borreliosis symptoms in erythema migrans patients with positive and negative Borrelia burgdorferi sensu lato skin culture.

Stupica D, Lusa L, Cerar T, Ružić-Sabljić E, Strle F.

Vector Borne Zoonotic Dis. 2011 Jul;11(7):883-9. doi: 10.1089/vbz.2010.0018. Epub 2010 Nov 17.

PMID:
21083376
5.

Differentiation of reinfection from relapse in recurrent Lyme disease.

Nadelman RB, Hanincová K, Mukherjee P, Liveris D, Nowakowski J, McKenna D, Brisson D, Cooper D, Bittker S, Madison G, Holmgren D, Schwartz I, Wormser GP.

N Engl J Med. 2012 Nov 15;367(20):1883-90. doi: 10.1056/NEJMoa1114362.

6.

The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans.

Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D, Aguero-Rosenfeld M, Wormser GP.

Am J Med. 1996 May;100(5):502-8.

PMID:
8644761
7.

Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.

Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL, Holman MS, Persing DH, Steere AC.

Ann Intern Med. 2002 Mar 19;136(6):421-8.

PMID:
11900494
8.

Long-term assessment of fatigue in patients with culture-confirmed Lyme disease.

Wormser GP, Weitzner E, McKenna D, Nadelman RB, Scavarda C, Nowakowski J.

Am J Med. 2015 Feb;128(2):181-4. doi: 10.1016/j.amjmed.2014.09.022. Epub 2014 Oct 15.

PMID:
25447620
9.

Xenodiagnosis to detect Borrelia burgdorferi infection: a first-in-human study.

Marques A, Telford SR 3rd, Turk SP, Chung E, Williams C, Dardick K, Krause PJ, Brandeburg C, Crowder CD, Carolan HE, Eshoo MW, Shaw PA, Hu LT.

Clin Infect Dis. 2014 Apr;58(7):937-45. doi: 10.1093/cid/cit939. Epub 2014 Feb 11.

10.

Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease.

Strle K, Jones KL, Drouin EE, Li X, Steere AC.

Am J Pathol. 2011 Jun;178(6):2726-39. doi: 10.1016/j.ajpath.2011.02.018.

11.

Burden and viability of Borrelia burgdorferi in skin and joints of patients with erythema migrans or lyme arthritis.

Li X, McHugh GA, Damle N, Sikand VK, Glickstein L, Steere AC.

Arthritis Rheum. 2011 Aug;63(8):2238-47. doi: 10.1002/art.30384.

12.
13.

Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii.

Strle F, Ružić-Sabljić E, Logar M, Maraspin V, Lotrič-Furlan S, Cimperman J, Ogrinc K, Stupica D, Nadelman RB, Nowakowski J, Wormser GP.

Vector Borne Zoonotic Dis. 2011 Sep;11(9):1253-8. doi: 10.1089/vbz.2010.0230. Epub 2011 May 25.

PMID:
21612533
14.

Evaluation of a genotyping method based on the ospA gene to detect Borrelia burgdorferi sensu lato in multiple samples of lyme borreliosis patients.

Floris R, Menardi G, Bressan R, Trevisan G, Ortenzio S, Rorai E, Cinco M.

New Microbiol. 2007 Oct;30(4):399-410.

15.

Mini erythema migrans--a sign of early Lyme borreliosis.

Weber K, Wilske B.

Dermatology. 2006;212(2):113-6.

PMID:
16484816
16.

CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Bechtold KT.

Clin Vaccine Immunol. 2016 Sep 6;23(9):757-66. doi: 10.1128/CVI.00071-16. Print 2016 Sep.

17.

Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings.

Liveris D, Wang G, Girao G, Byrne DW, Nowakowski J, McKenna D, Nadelman R, Wormser GP, Schwartz I.

J Clin Microbiol. 2002 Apr;40(4):1249-53.

18.

Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans.

Berger BW, Kaplan MH, Rothenberg IR, Barbour AG.

J Am Acad Dermatol. 1985 Sep;13(3):444-9.

PMID:
3902917
19.

[Re-infection with Borrelia burgdorferi s.l in a patient with a history of neuroborreliosis--case report].

Grygorczuk S, Pancewicz S, Zajkowska J, Kondrusik M, Swierzbińska R, Moniuszko A, Pawlak-Zalewska W.

Pol Merkur Lekarski. 2008 Sep;25(147):254-6. Polish.

PMID:
19112843
20.

Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease.

Liveris D, Schwartz I, McKenna D, Nowakowski J, Nadelman R, Demarco J, Iyer R, Bittker S, Cooper D, Holmgren D, Wormser GP.

Diagn Microbiol Infect Dis. 2012 Jul;73(3):243-5. doi: 10.1016/j.diagmicrobio.2012.03.026. Epub 2012 May 8.

Supplemental Content

Support Center